The Klinique Medical Clinic PCL (BKK:KLINIQ)
28.50
-0.50 (-1.72%)
Aug 11, 2026, 10:34 AM ICT
BKK:KLINIQ Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, BKK:KLINIQ stock has a consensus rating of "Buy" and an average price target of ฿31.33. The average 1-year stock price forecast is 9.93% higher than the current stock price, while the lowest is ฿28.00 (-1.75%) and the highest is ฿33.00 (+15.79%).
Price Target: ฿31.33 (+9.93%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BKK:KLINIQ stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Financial Forecast
Revenue This Year
4.23B
from 3.56B
Increased by 18.87%
Revenue Next Year
4.77B
from 4.23B
Increased by 12.88%
EPS This Year
1.97
from 1.65
Increased by 19.39%
EPS Next Year
2.23
from 1.97
Increased by 13.37%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is THB.